GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daesung Microbiological Labs Co Ltd (XKRX:036480) » Definitions » Debt-to-Asset

Daesung Microbiological Labs Co (XKRX:036480) Debt-to-Asset : 0.38 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Daesung Microbiological Labs Co Debt-to-Asset?

Daesung Microbiological Labs Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩3,981 Mil. Daesung Microbiological Labs Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩18,478 Mil. Daesung Microbiological Labs Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₩59,851 Mil. Daesung Microbiological Labs Co's debt to asset for the quarter that ended in Sep. 2024 was 0.38.


Daesung Microbiological Labs Co Debt-to-Asset Historical Data

The historical data trend for Daesung Microbiological Labs Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daesung Microbiological Labs Co Debt-to-Asset Chart

Daesung Microbiological Labs Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.35 0.36 0.34 0.37

Daesung Microbiological Labs Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.37 0.37 0.35 0.38

Competitive Comparison of Daesung Microbiological Labs Co's Debt-to-Asset

For the Biotechnology subindustry, Daesung Microbiological Labs Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daesung Microbiological Labs Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Daesung Microbiological Labs Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Daesung Microbiological Labs Co's Debt-to-Asset falls into.



Daesung Microbiological Labs Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Daesung Microbiological Labs Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(7595.915 + 16415.363) / 64290.285
=0.37

Daesung Microbiological Labs Co's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3981.429 + 18477.589) / 59850.814
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daesung Microbiological Labs Co  (XKRX:036480) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Daesung Microbiological Labs Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Daesung Microbiological Labs Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Daesung Microbiological Labs Co Business Description

Traded in Other Exchanges
N/A
Address
293 Sam-dong, Uiwang, Kyunggi-Do, KOR, 437-040
Daesung Microbiological Labs Co Ltd is engaged in manufacturing and selling vaccines for swine, poultry, canine, cattle, and fish in South Korea. The company offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals.

Daesung Microbiological Labs Co Headlines

No Headlines